Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

The introduction of immunotherapy into the treatment of cancer patients has revolutionised the oncological approach and significantly improved patient survival. The key drugs are immune checkpoint inhibitors (CPIs), whose mechanism of action is to elicit immune response against cancer cell antigens....

Descripción completa

Detalles Bibliográficos
Autores principales: Kamińska-Winciorek, Grażyna, Cybulska-Stopa, Bozena, Lugowska, Iwona, Ziobro, Marek, Rutkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791150/
https://www.ncbi.nlm.nih.gov/pubmed/31616210
http://dx.doi.org/10.5114/ada.2018.80272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791150/
https://www.ncbi.nlm.nih.gov/pubmed/31616210
http://dx.doi.org/10.5114/ada.2018.80272

Ejemplares similares